Balaxi Pharmaceuticals Limited (BALAXI.NS)

INR 79.69

(0.59%)

Total Liabilities Summary of Balaxi Pharmaceuticals Limited

Balaxi Pharmaceuticals Limited's latest annual total liabilities in 2023 was 569.79 Million INR , up 0.34% from previous year.
Balaxi Pharmaceuticals Limited's latest quarterly total liabilities in 2024 Q1 was -2.01 Billion INR , down -453.39% from previous quarter.
Balaxi Pharmaceuticals Limited reported annual total liabilities of 567.89 Million INR in 2022, down -10.29% from previous year.
Balaxi Pharmaceuticals Limited reported annual total liabilities of 633.06 Million INR in 2021, up 82.44% from previous year.
Balaxi Pharmaceuticals Limited reported quarterly total liabilities of 569.79 Million INR for 2023 FY, up 0.34% from previous quarter.
Balaxi Pharmaceuticals Limited reported quarterly total liabilities of 569.79 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Balaxi Pharmaceuticals Limited (2023 - 2012)

Historical Annual Total Liabilities of Balaxi Pharmaceuticals Limited (2023 - 2012)

Year	Total Liabilities	Total Liabilities Growth
2023	569.79 Million INR	0.34%
2022	567.89 Million INR	-10.29%
2021	633.06 Million INR	82.44%
2020	346.99 Million INR	321.88%
2019	82.25 Million INR	217.9%
2018	25.87 Million INR	1859.33%
2017	1.32 Million INR	-39.26%
2016	2.17 Million INR	5061.73%
2015	42.11 Thousand INR	-7.73%
2014	45.64 Thousand INR	-98.92%
2013	4.24 Million INR	-12.73%
2012	4.86 Million INR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	-2.01 Billion INR	-453.39%
2023 FY	569.79 Million INR	0.34%
2023 Q4	569.79 Million INR	0.0%
2023 Q3	- INR	-100.0%
2023 Q2	590 Million INR	0.0%
2023 Q1	- INR	-100.0%
2022 FY	567.89 Million INR	-10.29%
2022 Q4	567.89 Million INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q2	509.09 Million INR	0.0%
2022 Q1	- INR	-100.0%
2021 Q4	633.06 Million INR	0.0%
2021 FY	633.06 Million INR	82.44%
2021 Q3	- INR	-100.0%
2021 Q2	379.81 Million INR	0.0%
2021 Q1	- INR	-100.0%
2020 Q3	- INR	-100.0%
2020 Q4	346.99 Million INR	0.0%
2020 Q2	311.52 Million INR	0.0%
2020 FY	346.99 Million INR	321.88%
2020 Q1	- INR	-100.0%
2019 FY	82.25 Million INR	217.9%
2019 Q4	82.25 Million INR	0.0%
2019 Q3	- INR	-100.0%
2019 Q1	- INR	-100.0%
2019 Q2	39.07 Million INR	0.0%
2018 FY	25.87 Million INR	1859.33%
2018 Q3	- INR	-100.0%
2018 Q4	25.87 Million INR	0.0%
2018 Q1	- INR	-100.0%
2018 Q2	10.08 Million INR	0.0%
2017 Q2	2.25 Million INR	0.0%
2017 Q3	- INR	-100.0%
2017 Q4	1.32 Million INR	0.0%
2017 FY	1.32 Million INR	-39.26%
2017 Q1	- INR	-100.0%
2016 Q3	- INR	-100.0%
2016 FY	2.17 Million INR	5061.73%
2016 Q4	2.17 Million INR	0.0%
2016 Q2	4.95 Million INR	0.0%
2016 Q1	- INR	-100.0%
2015 FY	42.11 Thousand INR	-7.73%
2015 Q4	42.11 Thousand INR	0.0%
2014 FY	45.64 Thousand INR	-98.92%
2014 Q4	45.64 Thousand INR	0.0%
2013 FY	4.24 Million INR	-12.73%
2012 FY	4.86 Million INR	0.0%

Peer Total Liabilities Comparison of Balaxi Pharmaceuticals Limited

Name	Total Liabilities	Total Liabilities Difference